Insights

A new screening tool, the Neurological Disorders Depression Inventory-Epilepsy-Youth (NDDI-E-Y), effectively identified depression in 15% of pediatric epilepsy patients. This highlights the need for routine depression screening in youth with epilepsy.

Area of Science:

  • Pediatric Neurology
  • Clinical Psychology
  • Quality Improvement Science

Background:

  • Depression frequently co-occurs with epilepsy in youth, often remaining undiagnosed.
  • Under-recognition of depression in pediatric epilepsy patients can negatively impact quality of life and seizure management.
  • Effective screening tools are crucial for timely identification and intervention.

Purpose of the Study:

  • To implement and evaluate the effectiveness of the Neurological Disorders Depression Inventory-Epilepsy-Youth (NDDI-E-Y) for depression screening in a pediatric epilepsy clinic.
  • To assess the feasibility and impact of standardized depression screening in youth aged 12-17 with epilepsy.
  • To improve the recognition and management of depression in this vulnerable population.

Main Methods:

  • A pre-post quality improvement study design was employed.
  • The NDDI-E-Y tool was administered to youth (12-17 years) diagnosed with epilepsy.
  • Positive screens (scores > 32) triggered social work evaluation and mental health resource referrals; educational materials were provided.

Main Results:

  • Out of 176 evaluated patients, 112 completed the NDDI-E-Y.
  • A significant 15% (n=17) of patients screened positive for depression risk.
  • The screening process identified a notable prevalence of depression in the study cohort.

Conclusions:

  • Standardized depression screening using the NDDI-E-Y is feasible and recommended in outpatient pediatric epilepsy settings.
  • Early identification of depression through routine screening can lead to timely interventions, potentially improving patient outcomes.
  • Addressing depression is essential for comprehensive epilepsy management in youth.
Abstract